AstraZeneca PLC (ETR:ZEG)
160.70
+0.95 (0.59%)
Feb 5, 2026, 5:35 PM CET
AstraZeneca Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 58,739 | 54,073 | 45,811 | 44,351 | 37,417 | Upgrade
|
| Revenue | 58,739 | 54,073 | 45,811 | 44,351 | 37,417 | Upgrade
|
| Revenue Growth (YoY) | 8.63% | 18.04% | 3.29% | 18.53% | 40.58% | Upgrade
|
| Cost of Revenue | 10,746 | 9,638 | 8,045 | 8,641 | 12,005 | Upgrade
|
| Gross Profit | 47,993 | 44,435 | 37,766 | 35,710 | 25,412 | Upgrade
|
| Selling, General & Admin | 20,072 | 19,453 | 18,036 | 17,460 | 14,673 | Upgrade
|
| Research & Development | 13,851 | 12,243 | 10,306 | 9,669 | 8,049 | Upgrade
|
| Other Operating Expenses | -222 | -190 | -275 | -231 | -207 | Upgrade
|
| Operating Expenses | 33,701 | 31,506 | 28,067 | 26,898 | 22,515 | Upgrade
|
| Operating Income | 14,292 | 12,929 | 9,699 | 8,812 | 2,897 | Upgrade
|
| Interest Expense | -1,365 | -1,403 | -1,219 | -917 | -776 | Upgrade
|
| Interest & Investment Income | 360 | 345 | 301 | 81 | 43 | Upgrade
|
| Earnings From Equity Investments | -7 | -28 | -12 | -5 | -64 | Upgrade
|
| Currency Exchange Gain (Loss) | -31 | -42 | -34 | -16 | -20 | Upgrade
|
| Other Non Operating Income (Expenses) | -247 | -134 | -292 | -370 | -478 | Upgrade
|
| EBT Excluding Unusual Items | 13,002 | 11,667 | 8,443 | 7,585 | 1,602 | Upgrade
|
| Merger & Restructuring Charges | -262 | -1,154 | -581 | -4,201 | -1,283 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 776 | Upgrade
|
| Gain (Loss) on Sale of Assets | 154 | 60 | 292 | 216 | 509 | Upgrade
|
| Asset Writedown | -230 | -1,574 | -434 | -241 | -2,069 | Upgrade
|
| Legal Settlements | -218 | -48 | -1,013 | -789 | -48 | Upgrade
|
| Other Unusual Items | -44 | -260 | 192 | -69 | 248 | Upgrade
|
| Pretax Income | 12,402 | 8,691 | 6,899 | 2,501 | -265 | Upgrade
|
| Income Tax Expense | 2,169 | 1,650 | 938 | -792 | -380 | Upgrade
|
| Earnings From Continuing Operations | 10,233 | 7,041 | 5,961 | 3,293 | 115 | Upgrade
|
| Minority Interest in Earnings | -8 | -6 | -6 | -5 | -3 | Upgrade
|
| Net Income | 10,225 | 7,035 | 5,955 | 3,288 | 112 | Upgrade
|
| Net Income to Common | 10,225 | 7,035 | 5,955 | 3,288 | 112 | Upgrade
|
| Net Income Growth | 45.34% | 18.14% | 81.11% | 2835.71% | -96.50% | Upgrade
|
| Shares Outstanding (Basic) | 1,550 | 1,550 | 1,549 | 1,548 | 1,418 | Upgrade
|
| Shares Outstanding (Diluted) | 1,562 | 1,563 | 1,562 | 1,560 | 1,427 | Upgrade
|
| Shares Change (YoY) | -0.06% | 0.06% | 0.13% | 9.32% | 8.68% | Upgrade
|
| EPS (Basic) | 6.60 | 4.54 | 3.84 | 2.12 | 0.08 | Upgrade
|
| EPS (Diluted) | 6.54 | 4.50 | 3.81 | 2.11 | 0.08 | Upgrade
|
| EPS Growth | 45.33% | 18.11% | 80.57% | 2571.43% | -96.76% | Upgrade
|
| Free Cash Flow | 11,765 | 9,937 | 8,984 | 8,717 | 4,872 | Upgrade
|
| Free Cash Flow Per Share | 7.53 | 6.36 | 5.75 | 5.59 | 3.41 | Upgrade
|
| Dividend Per Share | 3.200 | 3.100 | 2.900 | 2.900 | 2.870 | Upgrade
|
| Dividend Growth | 3.23% | 6.90% | - | 1.04% | 2.50% | Upgrade
|
| Gross Margin | 81.71% | 82.18% | 82.44% | 80.52% | 67.92% | Upgrade
|
| Operating Margin | 24.33% | 23.91% | 21.17% | 19.87% | 7.74% | Upgrade
|
| Profit Margin | 17.41% | 13.01% | 13.00% | 7.41% | 0.30% | Upgrade
|
| Free Cash Flow Margin | 20.03% | 18.38% | 19.61% | 19.66% | 13.02% | Upgrade
|
| EBITDA | 19,280 | 17,567 | 14,275 | 13,744 | 6,701 | Upgrade
|
| EBITDA Margin | 32.82% | 32.49% | 31.16% | 30.99% | 17.91% | Upgrade
|
| D&A For EBITDA | 4,988 | 4,638 | 4,576 | 4,932 | 3,804 | Upgrade
|
| EBIT | 14,292 | 12,929 | 9,699 | 8,812 | 2,897 | Upgrade
|
| EBIT Margin | 24.33% | 23.91% | 21.17% | 19.87% | 7.74% | Upgrade
|
| Effective Tax Rate | 17.49% | 18.98% | 13.60% | - | - | Upgrade
|
| Revenue as Reported | 58,739 | 54,073 | 45,811 | 44,351 | 37,417 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.